Activation of the Peripheral Endocannabinoid System in Human ObesityStefan Engeli, Jens Jordan, Jana Böhnke et al.|Diabetes|2005Cited by 690
Potent Metalloporphyrin Peroxynitrite Decomposition Catalyst Protects Against the Development of Doxorubicin-Induced Cardiac DysfunctionPál Pacher, Csaba Szabó|Circulation|2003Cited by 277
Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell DeathHao Pan, Pál Pacher|Journal of Pharmacology and Experimental Therapeutics|2008Cited by 248
Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic CardiomyopathyMohanraj Rajesh, Pál Pacher|Diabetes|2012Cited by 248
Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseasesNathan A. Berger, Csaba Szabó, Andrew L. Salzman et al.|British Journal of Pharmacology|2017Cited by 210